Skip Navigation



Carcinogenesis Advance Access published online on November 9, 2005

Carcinogenesis, doi:10.1093/carcin/bgi265
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
27/4/811    most recent
bgi265v2
bgi265v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Crallan, R. A.
Right arrow Articles by Southgate, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crallan, R. A.
Right arrow Articles by Southgate, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
Received August 11, 2005
Revised October 31, 2005
Accepted November 2, 2005

REVIEW

Experimental models of human bladder carcinogenesis

R. A. Crallan 1, N. T. Georgopoulos 1, and J. Southgate 1*

1 Jack Birch Unit of Molecular Carcinogenesis, Department of Biology, University of York, York, Y010 5YW, United Kingdom

* To whom correspondence should be addressed.
J. Southgate, E-mail: js35{at}york.ac.uk


   Abstract

Bladder cancer is the fifth most common cancer in the UK, yet human bladder carcinogenesis remains poorly understood and the response of bladder tumours to radio- and chemo-therapy is unpredictable. The aims of this article are to review human bladder carcinogenesis and appraise the different in vitro and in vivo approaches that have been developed to study the process. The review considers how in vitro models based on normal human urothelial cells can be applied to human bladder cancer research. We conclude that recent advances in normal human urothelial cell culture offer novel approaches for defining urothelial tissue-specific responses to genotoxic and non-genotoxic carcinogens and elucidating the role of specific genes involved in the mechanisms of bladder carcinogenesis and malignant progression.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Gibbs, J. Schwartzman, V. Deng, and J. Alumkal
Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6
PNAS, September 29, 2009; 106(39): 16663 - 16668.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S.-H. Kim and S. V. Singh
D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells
Mol. Cancer Ther., July 1, 2009; 8(7): 1946 - 1954.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. V. Singh, R. Warin, D. Xiao, A. A. Powolny, S. D. Stan, J. A. Arlotti, Y. Zeng, E.-R. Hahm, S. W. Marynowski, A. Bommareddy, et al.
Sulforaphane Inhibits Prostate Carcinogenesis and Pulmonary Metastasis in TRAMP Mice in Association with Increased Cytotoxicity of Natural Killer Cells
Cancer Res., March 1, 2009; 69(5): 2117 - 2125.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Nian, B. Delage, J. T. Pinto, and R. H. Dashwood
Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter
Carcinogenesis, September 1, 2008; 29(9): 1816 - 1824.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Mimeault, P. P. Mehta, R. Hauke, and S. K. Batra
Functions of Normal and Malignant Prostatic Stem/Progenitor Cells in Tissue Regeneration and Cancer Progression and Novel Targeting Therapies
Endocr. Rev., April 1, 2008; 29(2): 234 - 252.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Kopelovich, J. R. Fay, C. C. Sigman, and J. A. Crowell
The Mammalian Target of Rapamycin Pathway as a Potential Target for Cancer Chemoprevention
Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1330 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Herman-Antosiewicz, H. Xiao, K. L. Lew, and S. V. Singh
Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line
Mol. Cancer Ther., May 1, 2007; 6(5): 1673 - 1681.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C.-Y. Jin, D.-O. Moon, J.-D. Lee, M.-S. Heo, Y. H. Choi, C.-M. Lee, Y.-M. Park, and G.-Y. Kim
Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through downregulation of ERK and Akt in lung adenocarcinoma A549 cells
Carcinogenesis, May 1, 2007; 28(5): 1058 - 1066.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Pledgie-Tracy, M. D. Sobolewski, and N. E. Davidson
Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines
Mol. Cancer Ther., March 1, 2007; 6(3): 1013 - 1021.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. C. Myzak, P. Tong, W.-M. Dashwood, R. H. Dashwood, and E. Ho
Sulforaphane Retards the Growth of Human PC-3 Xenografts and Inhibits HDAC Activity in Human Subjects
Experimental Biology and Medicine, February 1, 2007; 232(2): 227 - 234.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Choi, K. L. Lew, H. Xiao, A. Herman-Antosiewicz, D. Xiao, C. K. Brown, and S. V. Singh
D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1
Carcinogenesis, January 1, 2007; 28(1): 151 - 162.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. H. Dashwood
Frontiers in Polyphenols and Cancer Prevention
J. Nutr., January 1, 2007; 137(1): 267S - 269S.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. A. Ritz, J. Wan, and D. Diaz-Sanchez
Sulforaphane-stimulated phase II enzyme induction inhibits cytokine production by airway epithelial cells stimulated with diesel extract
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L33 - L39.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.